Positions and Numbers of FKS Mutations in Candida albicans Selectively Influence In Vitro and In Vivo Susceptibilities to Echinocandin Treatment

Infectious Diseases Society of America

Enders, J. F. (1969) · The Journal of Infectious Diseases · doi:10.1093/infdis/119.3.317 · Cited by 3,305 · see citing works

Clinical Practice Guidelines for the Management Candidiasis: 2009 Update by the Infectious Diseases Society of America

Pappas, P. G., Kauffman, C. A., Andes, D., Benjamin, D. K., Calandra, T. F., Edwards, J. E., Filler, S. G., Fisher, J. F., Kullberg, B.-J., Zeichner, L. O., et al. (2009) · Clinical Infectious Diseases · doi:10.1086/596757 · Cited by 3,191 · see citing works

Antibiotic resistance and its cost: is it possible to reverse resistance?

Andersson, D. I., & Hughes, D. (2010) · Nature Reviews Microbiology · doi:10.1038/nrmicro2319 · Cited by 2,302 · see citing works

Isolation of the Candida albicans gene for orotidine-5′-phosphate decarboxylase by complementation of S. cerevisiae ura3 and E. coli pyrF mutations

Gillum, A. M., Tsay, E. Y. H., & Kirsch, D. R. (1984) · Molecular and General Genetics MGG · doi:10.1007/bf00328721 · Cited by 1,253 · see citing works

Evolution of pathogenicity and sexual reproduction in eight Candida genomes

Butler, G., Rasmussen, M. D., Lin, M. F., Santos, M. A. S., Sakthikumar, S., Munro, C. A., Rheinbay, E., Grabherr, M., Forche, A., Reedy, J. L., et al. (2009) · Nature · doi:10.1038/nature08064 · Cited by 1,065 · see citing works

Antifungal drug resistance: mechanisms, epidemiology, and consequences for treatment

Pfaller, M. A. (2012) · The American Journal of Medicine · doi:10.1016/j.amjmed.2011.11.001 · Cited by 903 · see citing works

The SAT1 flipper, an optimized tool for gene disruption in Candida albicans

Reuß, O., Vik, Å., Kolter, R., & Morschhäuser, J. (2004) · Gene · doi:10.1016/j.gene.2004.06.021 · Cited by 744 · see citing works

Clinical Practice Guidelines for the Management of Candidiasis: 2009 Update by the Infectious Diseases Society of America

Parczewska, O. K., Posaconazol, przeciwgrzybicze, L., Anidulafungina, Micafungina, & wrażliwość, O. (2009) · Cited by 656 · see citing works

Resistance to echinocandin-class antifungal drugs.

Perlin, D. S. (2007) · Drug Resistance Updates · doi:10.1016/j.drup.2007.04.002 · Cited by 512 · see citing works

EUCAST technical note on the EUCAST definitive document EDef 7.2: method for the determination of broth dilution minimum inhibitory concentrations of antifungal agents for yeasts EDef 7.2 (EUCAST-AFST)

Arendrup, M. C., Cuenca-Estrella, M., Lass-Flörl, C., & Hope, W. (2012) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2012.03880.x · Cited by 451 · see citing works

Specific Substitutions in the Echinocandin Target Fks1p Account for Reduced Susceptibility of Rare Laboratory and Clinical <i>Candida</i> sp. Isolates

Park, S., Kelly, R., Kahn, J. N., Robles, J., Hsu, M.-J., Register, E., Li, W., Vyas, V., Fan, H., Abruzzo, G., et al. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.8.3264-3273.2005 · Cited by 434 · see citing works

Invasive candidiasis as a cause of sepsis in the critically ill patient

Delaloye, J., & Calandra, T. (2013) · Virulence · doi:10.4161/viru.26187 · Cited by 380 · see citing works

Hsp90 Governs Echinocandin Resistance in the Pathogenic Yeast Candida albicans via Calcineurin

Singh, S. D., Robbins, N., Zaas, A. K., Schell, W. A., Perfect, J. R., & Cowen, L. E. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000532 · Cited by 362 · cited 2× · see citing works

ESCMID guideline for the diagnosis and management of Candida diseases 2012: adults with haematological malignancies and after haematopoietic stem cell transplantation (HCT)

Ullmann, A. J., Akova, M., Herbrecht, R., Viscoli, C., Arendrup, M. C., Arikan-Akdagli, S., Bassetti, M., Bille, J., Calandra, T., Castagnola, E., et al. (2012) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12041 · Cited by 334 · see citing works

Correlating Echinocandin MIC and Kinetic Inhibition of <i>fks1</i> Mutant Glucan Synthases for <i>Candida albicans</i> : Implications for Interpretive Breakpoints

Garcia-Effron, G., Park, S., & Perlin, D. S. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01162-08 · Cited by 256 · see citing works

<i>Candida</i> Bloodstream Infections: Comparison of Species Distributions and Antifungal Resistance Patterns in Community-Onset and Nosocomial Isolates in the SENTRY Antimicrobial Surveillance Program, 2008-2009

Pfaller, M. A., Moet, G. J., Messer, S. A., Jones, R. N., & Castanheira, M. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01079-10 · Cited by 238 · see citing works

Echinocandin and Triazole Antifungal Susceptibility Profiles for Clinical Opportunistic Yeast and Mold Isolates Collected from 2010 to 2011: Application of New CLSI Clinical Breakpoints and Epidemiological Cutoff Values for Characterization of Geographic and Temporal Trends of Antifungal Resistance

Pfaller, M. A., Messer, S. A., Woosley, L. N., Jones, R. N., & Castanheira, M. (2013) · Journal of Clinical Microbiology · doi:10.1128/jcm.00308-13 · Cited by 237 · see citing works

Interlaboratory variability of caspofungin MICs for Candida spp. using CLSI and EUCAST methods: Should the clinical laboratory be testing this agent?

Espinel-Ingroff, A., Arendrup, M. C., Pfaller, M. A., Bonfietti, L. X., Bustamante, B., Canton, E., Chryssanthou, E., Cuenca-Estrella, M., Dannaoui, E., Fothergill, A., et al. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01519-13 · Cited by 216 · see citing works

Elevated Cell Wall Chitin in Candida albicans Confers Echinocandin Resistance <i>In Vivo</i>

Lee, K. K., MacCallum, D. M., Jacobsen, M. D., Walker, L. A., Odds, F. C., Gow, N. A. R., & Munro, C. A. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00683-11 · Cited by 209 · see citing works

Fitness and virulence costs of Candida albicans FKS1 hot spot mutations associated with echinocandin resistance.

Ben-Ami, R., Garcia-Effron, G., Lewis, R. E., Gamarra, S., Leventakos, K., Perlin, D. S., & Kontoyiannis, D. P. (2011) · The Journal of Infectious Diseases · doi:10.1093/infdis/jir351 · Cited by 162 · see citing works

Untitled work

(2013) · PubMed · Cited by 150 · see citing works

Fks1 and Fks2 Are Functionally Redundant but Differentially Regulated in Candida glabrata: Implications for Echinocandin Resistance

Katiyar, S. K., Alastruey-Izquierdo, A., Healey, K. R., Johnson, M. E., Perlin, D. S., & Edlind, T. D. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00813-12 · Cited by 148 · see citing works

<i>Candida</i> spp. with Acquired Echinocandin Resistance, France, 2004–20101

Dannaoui, E., Desnos-Ollivier, M., Garcia-Hermoso, D., Grenouillet, F., Cassaing, S., Baixench, M.-T., Bretagne, S., Dromer, F., Lortholary, O., & the French Mycoses Study Group (2012) · Emerging infectious diseases · doi:10.3201/eid1801.110556 · Cited by 130 · see citing works

Differential <i>In Vivo</i> Activities of Anidulafungin, Caspofungin, and Micafungin against Candida glabrata Isolates with and without <i>FKS</i> Resistance Mutations

Arendrup, M. C., Perlin, D. S., Jensen, R. H., Howard, S. J., Goodwin, J., & Hope, W. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.06369-11 · Cited by 117 · see citing works

The Candida albicans Cdr2p ATP‐binding cassette (ABC) transporter confers resistance to caspofungin

Schuetzer‐Muehlbauer, M., Willinger, B., Krapf, G., Enzinger, S., Presterl, E., & Kuchler, K. (2003) · Molecular Microbiology · doi:10.1046/j.1365-2958.2003.03430.x · Cited by 111 · see citing works

Rapid Emergence of Echinocandin Resistance in Candida glabrata Resulting in Clinical and Microbiologic Failure

Lewis, J. S., Wiederhold, N. P., Wickes, B. L., Patterson, T. F., & Jorgensen, J. H. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01144-13 · Cited by 101 · see citing works

Characterization of yeast isolates originating from Hungarian dairy products using traditional and molecular identification techniques

Vasdinyei, R. (2003) · International Journal of Food Microbiology · doi:10.1016/s0168-1605(03)00251-4 · Cited by 96 · see citing works

Development and verification of fingerprinting probes for Candida glabrata

Lockhart, S. R., Joly, S., Pujol, C., Sobel, J. D., Pfaller, M. A., & Soll, D. R. (1997) · Microbiology · doi:10.1099/00221287-143-12-3733 · Cited by 69 · see citing works

Caspofungin Etest susceptibility testing of Candida species: risk of misclassification of susceptible isolates of C. glabrata and C. krusei when adopting the revised CLSI caspofungin breakpoints.

Arendrup, M. C., Pfaller, M. A., & the Danish Fungaemia Study Group (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00355-12 · Cited by 67 · see citing works

Caspofungin Dose Escalation for Invasive Candidiasis Due to Resistant Candida albicans

Wiederhold, N. P., Najvar, L. K., Bocanegra, R. A., Kirkpatrick, W. R., & Patterson, T. F. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01750-10 · Cited by 61 · see citing works

Disseminated Candidiasis Caused by Candida albicans with Amino Acid Substitutions in Fks1 at Position Ser645 Cannot Be Successfully Treated with Micafungin

Slater, J. L., Howard, S. J., Sharp, J., Goodwin, J., Gregson, L., Alastruey‐Izquierdo, A., Arendrup, M. C., Warn, P. A., Perlin, D. S., & Hope, W. W. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01686-10 · Cited by 52 · see citing works

Stepwise development of a homozygous S80P substitution in Fks1p, conferring echinocandin resistance in Candida tropicalis.

Jensen, R. H., Johansen, H. K., & Arendrup, M. C. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01193-12 · Cited by 47 · see citing works

Clinically significant micafungin resistance in Candida albicans involves modification of a glucan synthase catalytic subunit GSC1 (FKS1) allele followed by loss of heterozygosity

Niimi, K., Monk, B. C., Hirai, A., Hatakenaka, K., Umeyama, T., Lamping, E., Maki, K., Tanabe, K., Kamimura, T., Ikeda, F., et al. (2010) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq073 · Cited by 47 · see citing works

<scp>EUCAST</scp> Technical Note on <i>Candida</i> and micafungin, anidulafungin and fluconazole

Cavling Arendrup, M., Cuenca‐Estrella, M., Lass‐Flörl, C., Hope, W. W., & The European Committee on Antimicrobial Susceptibility Testing – Subcommittee on Antifungal Susceptibility Testing (EUCAST‐AFST) (2014) · Mycoses · doi:10.1111/myc.12170 · Cited by 43 · see citing works

Resistance to echinocandins comes at a cost: The impact of FKS1 hotspot mutations on Candida albicans fitness and virulence

Ben-Ami, R., & Kontoyiannis, D. P. (2012) · Virulence · doi:10.4161/viru.3.1.18886 · Cited by 39 · see citing works

Optical Densities Reduce Odds of Heparin-induced Thrombocytopenia Over-diagnosis

Warkentin, T. E. (2011) · The American Journal of Medicine · doi:10.1016/j.amjmed.2011.10.001 · Cited by 35 · see citing works

Fungal infection in patients after liver transplantation in years 2003 to 2012

Guan, X. (2012) · Annals of Transplantation · doi:10.12659/aot.883695 · Cited by 34 · see citing works

Epidemiological characteristics of Candida species colonizing oral and rectal sites of Jordanian infants

Issa, S. Y., Badran, E., Akl, K., & Shehabi, A. A. (2011) · BMC Pediatrics · doi:10.1186/1471-2431-11-79 · Cited by 31 · see citing works

Molecular typing of Candida albicans isolates from patients and health care workers in a neonatal intensive care unit

Abdeljelil, J. B., Saghrouni, F., Noumi, E., Valentı́n, E., Chatti, N., Boukadida, J., Saïd, M. B., & Agudo, L. D. C. (2011) · Journal of Applied Microbiology · doi:10.1111/j.1365-2672.2011.05121.x · Cited by 25 · see citing works

Successful Treatment of Azole-resistant Chronic Mucocutaneous Candidosis with Caspofungin

Jayasinghe, M., Schmidt, S. H., Walker, B., Röcken, M., & Schaller, M. (2006) · Acta Dermato Venereologica · doi:10.2340/00015555-0165 · Cited by 10 · see citing works

Multidrug-Resistant Candida: Epidemiology, Molecular Mechanisms, and Treatment

Arendrup, M. C., & Patterson, T. F. (2017) · The Journal of Infectious Diseases · doi:10.1093/infdis/jix131 · Cited by 707 · see citing works

The Antifungal Pipeline: Fosmanogepix, Ibrexafungerp, Olorofim, Opelconazole, and Rezafungin

Hoenigl, M., Sprute, R., Egger, M., Arastehfar, A., Cornely, O. A., Krause, R., Lass-Flörl, C., Prattes, J., Spec, A., Thompson, G. R., et al. (2021) · Drugs · doi:10.1007/s40265-021-01611-0 · Cited by 467 · see citing works

Antifungal drug resistance among <i>Candida</i> species: mechanisms and clinical impact

Sanguinetti, M., Posteraro, B., & Lass‐Flörl, C. (2015) · Mycoses · doi:10.1111/myc.12330 · Cited by 394 · see citing works

Candida albicans - Biology, molecular characterization, pathogenicity, and advances in diagnosis and control – An update

Dadar, M., Tiwari, R., Karthik, K., Chakraborty, S., Shahali, Y., & Dhama, K. (2018) · Microbial Pathogenesis · doi:10.1016/j.micpath.2018.02.028 · Cited by 338 · see citing works

Mechanisms of echinocandin antifungal drug resistance

Perlin, D. S. (2015) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12831 · Cited by 313 · see citing works

Echinocandin resistance: an emerging clinical problem?

Arendrup, M. C., & Perlin, D. S. (2014) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0000000000000111 · Cited by 299 · see citing works

How to interpret MICs of antifungal compounds according to the revised clinical breakpoints v. 10.0 European committee on antimicrobial susceptibility testing (EUCAST)

Arendrup, M. C., Friberg, N., Ma, M., Kahlmeter, G., Meletiadis, J., Guinea, J., Arendrup, M., Meletiadis, J., Guinea, J., Friberg, N., et al. (2020) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2020.06.007 · Cited by 248 · see citing works

Genome-Wide Analysis of Experimentally Evolved Candida auris Reveals Multiple Novel Mechanisms of Multidrug Resistance

Carolus, H., Pierson, S., Muñoz, J. F., Subotić, A., Cruz, R. B., Cuomo, C. A., & Van Dijck, P. (2021) · mBio · doi:10.1128/mbio.03333-20 · Cited by 211 · see citing works

Dermatophyte Resistance to Antifungal Drugs: Mechanisms and Prospectus

Martinez-Rossi, N. M., Bitencourt, T. A., Peres, N. T. A., Lang, E. A. S., Gomes, E. V., Quaresemin, N. R., Martins, M. P., Lopes, L. R., & Rossi, A. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.01108 · Cited by 189 · see citing works

A comprehensive overview of the medicinal chemistry of antifungal drugs: perspectives and promise

Howard, K. C., Dennis, E. K., Watt, D. S., & Garneau‐Tsodikova, S. (2020) · Chemical Society Reviews · doi:10.1039/c9cs00556k · Cited by 147 · see citing works

Echinocandins in antifungal pharmacotherapy

Patil, A., & Majumdar, S. (2017) · Journal of Pharmacy and Pharmacology · doi:10.1111/jphp.12780 · Cited by 145 · see citing works

Resistance of Candida spp. to antifungal drugs in the ICU: where are we now?

Maubon, D., Garnaud, C., Calandra, T., Sanglard, D., & Cornet, M. (2014) · Intensive Care Medicine · doi:10.1007/s00134-014-3404-7 · Cited by 135 · see citing works

European candidaemia is characterised by notable differential epidemiology and susceptibility pattern: Results from the ECMM Candida III study

Arendrup, M. C., Arıkan-Akdağlı, S., Jørgensen, K. M., Barac, A. M., Steinmann, J., Toscano, C., Arsić-Arsenijević, V. S., Sartor, A., Lass‐Flörl, C., Hamprecht, A. G., et al. (2023) · Journal of Infection · doi:10.1016/j.jinf.2023.08.001 · Cited by 130 · see citing works

Echinocandin Resistance, Susceptibility Testing and Prophylaxis: Implications for Patient Management

Perlin, D. S. (2014) · Drugs · doi:10.1007/s40265-014-0286-5 · Cited by 99 · see citing works

Molecular mechanisms of acquired antifungal drug resistance in principal fungal pathogens and EUCAST guidance for their laboratory detection and clinical implications

Rogers, T. R., Verweij, P. E., Castanheira, M., Dannaoui, E., White, P. L., Arendrup, M. C., Subcommittee on Antifungal Susceptibility Testing (AFST) of the ESCMID European Committee for Antimicrobial Susceptibility Testing (EUCAST), Arendrup, M. C., Arikan-Akdagli, S., Barchiesi, F., et al. (2022) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkac161 · Cited by 82 · see citing works

Sterol 14α-Demethylase Ligand-Binding Pocket-Mediated Acquired and Intrinsic Azole Resistance in Fungal Pathogens

Rosam, K., Monk, B. C., & Lackner, M. (2020) · Journal of Fungi · doi:10.3390/jof7010001 · Cited by 78 · see citing works

Clinical perspectives on echinocandin resistance among Candida species

Shields, R. K., Nguyen, M. H., & Clancy, C. J. (2015) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0000000000000215 · Cited by 75 · see citing works

Molecular diagnostic methods for invasive fungal disease: the horizon draws nearer?

Halliday, C. L., Kidd, S. E., Sorrell, T. C., & Chen, S. C.-A. (2015) · Pathology · doi:10.1097/pat.0000000000000234 · Cited by 52 · see citing works

Culture-Independent Molecular Methods for Detection of Antifungal Resistance Mechanisms and Fungal Identification

Perlin, D. S., & Wiederhold, N. P. (2017) · The Journal of Infectious Diseases · doi:10.1093/infdis/jix121 · Cited by 50 · see citing works

Overcoming the Resistance Hurdle: Pharmacokinetic-Pharmacodynamic Target Attainment Analyses for Rezafungin (CD101) against Candida albicans and Candida glabrata

Bader, J. C., Lakota, E. A., Flanagan, S., Ong, V. S., Sandison, T., Rubino, C. M., Bhavnani, S. M., & Ambrose, P. G. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02614-17 · Cited by 44 · see citing works

The novel oral glucan synthase inhibitor SCY-078 shows in vitro activity against sessile and planktonic Candida spp

Marcos-Zambrano, L. J., Gómez-Perosanz, M., Escribano, P., Bouza, E., & Guinea, J. (2017) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkx010 · Cited by 44 · see citing works

Pan-azole-resistantCandida tropicaliscarrying homozygouserg11mutations at position K143R: a new emerging superbug?

Xisto, M. I. D. D. S., Caramalho, R., Rocha, D. A. S., Ferreira‐Pereira, A., Sartori, B., Barreto‐Bergter, E., Junqueira, M. L., Lass‐Flörl, C., & Lackner, M. (2016) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkw558 · Cited by 44 · see citing works

Echinocandin Resistance in Candida Species: a Review of Recent Developments

Wiederhold, N. P. (2016) · Current Infectious Disease Reports · doi:10.1007/s11908-016-0549-2 · Cited by 41 · see citing works

Molecular Diagnostics for Invasive Fungal Diseases: Current and Future Approaches

Pham, D., Sivalingam, V., Tang, H. M., Montgomery, J. M., Chen, S. C. ‐., & Halliday, C. L. (2024) · Journal of Fungi · doi:10.3390/jof10070447 · Cited by 44 · see citing works

Therapeutic Drug Monitoring of the Echinocandin Antifungal Agents: Is There a Role in Clinical Practice? A Position Statement of the Anti-Infective Drugs Committee of the International Association of Therapeutic Drug Monitoring and Clinical Toxicology

Kim, H. Y., Baldelli, S., Märtson, A., STOCKER, S. L., Alffenaar, J. C., Cattaneo, D., & Marriott, D. J. E. (2021) · Therapeutic Drug Monitoring · doi:10.1097/ftd.0000000000000931 · Cited by 39 · see citing works

Targeting Candida spp. to develop antifungal agents

Salci, T. P., Negri, M., Abadio, A. K. R., Svidzinski, T. I. E., & Kioshima, É. S. (2018) · Drug Discovery Today · doi:10.1016/j.drudis.2018.01.003 · Cited by 35 · see citing works

A synthetic peptide mimic kills Candida albicans and synergistically prevents infection

Schaefer, S., Vij, R., Sprague, J. L., Austermeier, S., Dinh, H., Judzewitsch, P. R., Müller‐Loennies, S., Silva, T. L., Seemann, E. A., Qualmann, B., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-50491-x · Cited by 38 · see citing works

Epidemiology of Echinocandin Resistance in Candida

Grossman, N. T., Chiller, T. M., & Lockhart, S. R. (2014) · Current Fungal Infection Reports · doi:10.1007/s12281-014-0209-7 · Cited by 28 · see citing works

Resistance to echinocandin antifungal agents in the United Kingdom in clinical isolates of Candida glabrata: Fifteen years of interpretation and assessment

Fraser, M., Borman, A. M., Thorn, R. M. S., & Lawrance, L. M. (2019) · Medical Mycology · doi:10.1093/mmy/myz053 · Cited by 26 · see citing works

Sbg1 Is a Novel Regulator for the Localization of the β-Glucan Synthase Bgs1 in Fission Yeast

Davidson, R., Pontasch, J., & Wu, J. (2016) · PLoS ONE · doi:10.1371/journal.pone.0167043 · Cited by 25 · see citing works

The Microevolution of Antifungal Drug Resistance in Pathogenic Fungi

Boyce, K. J. (2023) · Microorganisms · doi:10.3390/microorganisms11112757 · Cited by 25 · see citing works

Large-scale genome mining allows identification of neutral polymorphisms and novel resistance mutations in genes involved in Candida albicans resistance to azoles and echinocandins

Sitterlé, E., Coste, A. T., Obadia, T., Maufrais, C., Chauvel, M., Sertour, N., Sanglard, D., Puel, A., d’Enfert, C., & Bougnoux, M. (2019) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkz537 · Cited by 23 · see citing works

Modeling of intravenous caspofungin administration using an intestine-on-chip reveals altered Candida albicans microcolonies and pathogenicity

Kaden, T., Alonso‐Román, R., Akbarimoghaddam, P., Mosig, A. S., Graf, K., Raasch, M., Hoffmann, B., Figge, M. T., Hube, B., & Gresnigt, M. S. (2024) · Biomaterials · doi:10.1016/j.biomaterials.2024.122525 · Cited by 22 · see citing works

Genomics‐driven discovery of a novel self‐resistance mechanism in the echinocandin‐producing fungus Pezicula radicicola

Yue, Q., Li, Y., Chen, L., Zhang, X., Liu, X., An, Z., & Bills, G. F. (2018) · Environmental Microbiology · doi:10.1111/1462-2920.14089 · Cited by 22 · see citing works

Antifungal resistance: Emerging mechanisms and implications (Review)

Kadariswantiningsih, I. N., Empitu, M. A., Santosa, T., & Alimu, Y. (2025) · Molecular Medicine Reports · doi:10.3892/mmr.2025.13612 · Cited by 24 · see citing works

Antimicrobial, antioxidant and antileishmanial activities of Ziziphus lotus leaves

Hammi, K. M., Essid, R., Khadraoui, N., Ksouri, R., Majdoub, H., & Tabbene, O. (2022) · Archives of Microbiology · doi:10.1007/s00203-021-02733-5 · Cited by 20 · see citing works

Genotypic and phenotypic characterization of Candida albicans Lebanese hospital isolates resistant and sensitive to caspofungin

Toutounji, M., Tokajian, S. T., & Khalaf, R. A. (2019) · Fungal Genetics and Biology · doi:10.1016/j.fgb.2019.02.008 · Cited by 19 · see citing works

Recurrent episodes of Candidemia due to Candida glabrata, Candida tropicalis and Candida albicans with acquired echinocandin resistance

Grosset, M., Desnos‐Ollivier, M., Godet, C., Kauffmann‐Lacroix, C., & Roblot, F. (2016) · Medical Mycology Case Reports · doi:10.1016/j.mmcr.2016.12.004 · Cited by 19 · see citing works

Minimal Inhibitory Concentration (MIC)-Phenomena in Candida albicans and Their Impact on the Diagnosis of Antifungal Resistance

Binder, U., Aigner, M., Risslegger, B., Hörtnagl, C., Lass‐Flörl, C., & Lackner, M. (2019) · Journal of Fungi · doi:10.3390/jof5030083 · Cited by 19 · see citing works

Sphingolipid Inhibitors as an Alternative to Treat Candidiasis Caused by Fluconazole-Resistant Strains

Rollin‐Pinheiro, R., Bayona-Pacheco, B. L., Domingos, L. T. S., Curvelo, J. A. D. R., de Castro, G. M. M., Barreto‐Bergter, E., & Ferreira‐Pereira, A. (2021) · Pathogens · doi:10.3390/pathogens10070856 · Cited by 18 · see citing works

Caspofungin resistance in Candida albicans: genetic factors and synergistic compounds for combination therapies

Perrine-Walker, F. M. (2022) · Brazilian Journal of Microbiology · doi:10.1007/s42770-022-00739-9 · Cited by 19 · see citing works

N -Chlorotaurine Exhibits Fungicidal Activity against Therapy-Refractory Scedosporium Species and Lomentospora prolificans

Lackner, M., Binder, U., Reindl, M., Gönül, B., Fankhauser, H., Mair, C., & Nagl, M. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00957-15 · Cited by 17 · see citing works

Molecular Analysis of Resistance and Detection of Non-Wild-Type Strains Using Etest Epidemiological Cutoff Values for Amphotericin B and Echinocandins for Bloodstream Candida Infections from a Tertiary Hospital in Qatar

Taj‐Aldeen, S. J., Salah, H., Perez, W. B., AlMaslamani, M. A. R. S., Motyl, M. R., AbdulWahab, A., Healey, K. R., & Perlin, D. S. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00214-18 · Cited by 16 · see citing works

Antifungal Resistance Testing and Implications for Management

Badali, H., & Wiederhold, N. P. (2019) · Current Fungal Infection Reports · doi:10.1007/s12281-019-00354-6 · Cited by 16 · see citing works

Roles of the novel coiled-coil protein Rng10 in septum formation during fission yeast cytokinesis

Liu, Y., Lee, I., Sun, M., Lower, C. A., Runge, K. W., Ma, J., & Wu, J. (2016) · Molecular Biology of the Cell · doi:10.1091/mbc.e16-03-0156 · Cited by 15 · see citing works

Characterization of Key Bio–Nano Interactions between Organosilica Nanoparticles and Candida albicans

Kesarwani, V., Kelly, H. G., Shankar, M., Robinson, K. J., Kent, S. J., Traven, A., & Corrie, S. R. (2019) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.9b10853 · Cited by 15 · see citing works

Echinocandins Susceptibility Patterns of 2,787 Yeast Isolates: Importance of the Thresholds for the Detection of FKS Mutations

Desnos-Ollivier, M., Bretagne, S., Lortholary, O., Dromer, F., & the French Mycoses Study Group N. Brieu CH Aix, T. C. (2022) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01725-21 · Cited by 13 · see citing works

Development of Echinocandin Resistance in Candida haemulonii: An Emergent, Widespread, and Opportunistic Fungal Pathogen

Silva, L. N., Ramos, L. S., Oliveira, S. S. C., Magalhães, L. B., Cypriano, J. B. S., Abreu, F. D. Á., Macêdo, A. J., Branquinha, M. H., & dos Santos, A. L. S. (2023) · Journal of Fungi · doi:10.3390/jof9080859 · Cited by 13 · see citing works

Mutational landscape and molecular bases of echinocandin resistance in Saccharomyces cerevisiae

Durand, R., Torbey, A. G., Giguere, M., Pageau, A., Dubé, A. K., Lagüe, P., & Landry, C. R. (2026) · Genetics · doi:10.1093/genetics/iyag055 · Cited by 13 · see citing works

Comparative evaluation of antifungal susceptibility testing methods of invasive Candida species and detection of FKS genes mutations in caspofungin intermediate and resistant isolates

ElFeky, D. S., El-Wakil, D. M., Mwafy, M. M., Atia, M. M. A., & Gohar, N. M. (2025) · BMC Infectious Diseases · doi:10.1186/s12879-024-10435-8 · Cited by 9 · see citing works

Expression of ERG11 and efflux pump genes CDR1, CDR2 and SNQ2 in voriconazole susceptible and resistant Candida glabrata strains

Navarro-Rodríguez, P., Martín‐Vicente, A., López‐Fernández, L., Guarro, J., & Capilla, J. (2019) · Medical Mycology · doi:10.1093/mmy/myz014 · Cited by 9 · see citing works

Rifaximin use favoured micafungin-resistant Candida spp. infections in recipients of allogeneic hematopoietic cell transplantation

Marzuttini, F., Mancusi, A., Bonato, S., Griselli, M., Tricarico, S., Casarola, G., Paradiso, M., Ruggeri, L., Terenzi, A., Merluzzi, M., et al. (2021) · Annals of Hematology · doi:10.1007/s00277-021-04569-x · Cited by 7 · see citing works

Rapamycin and caspofungin show synergistic antifungal effects in caspofungin-susceptible and caspofungin-resistant Candida strains in vitro

Lefranc, M., Accoceberry, I., Fitton‐Ouhabi, V., Biteau, N., & Noël, T. (2023) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkad359 · Cited by 7 · see citing works

Candida albicans Can Survive Antifungal Surface Coatings on Surfaces with Microcone Topography

Chakraborty, A., Jasieniak, M., Coad, B. R., & Griesser, H. J. (2021) · ACS Applied Bio Materials · doi:10.1021/acsabm.1c00307 · Cited by 8 · see citing works

Candida albicans Genes Modulating Echinocandin Susceptibility of Caspofungin-Adapted Mutants Are Constitutively Expressed in Clinical Isolates with Intermediate or Full Resistance to Echinocandins

Yadav, A., Sah, S. K., Perlin, D. S., & Rustchenko, E. P. (2024) · Journal of Fungi · doi:10.3390/jof10030224 · Cited by 5 · see citing works

The State-of-the-Art Mycology Laboratory: Visions of the Future

Arendrup, M. C., Posteraro, B., Sanguinetti, M., & Guinea, J. (2014) · Current Fungal Infection Reports · doi:10.1007/s12281-014-0212-z · Cited by 5 · see citing works

Multidrug- and Cross-Resistant Candida: the Looming Threat

Lackner, M., Martín‐Vicente, A., & Lass‐Flörl, C. (2014) · Current Fungal Infection Reports · doi:10.1007/s12281-014-0210-1 · Cited by 4 · see citing works

Chemical Profiling of Candida albicans Growth Phases by Vibrational Spectroscopy

Pebotuwa, S., Kostoulias, X., Wood, B. R., Peleg, A. Y., & Kochan, K. (2025) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.5c00539 · Cited by 2 · see citing works

Resistance in Candida albicans: Exploring the Cell Wall Barrier by Proteomics

Giuseppina, B. M., & Angiolella, L. (2015) · Chemotherapy Open access · doi:10.4172/2167-7700.1000165 · Cited by 2 · see citing works

Demonstration of Mutation Development and Virulence Change in Reference Candida Strains Exposed to Caspofungin

Bozkurt, N. B., & Kalkancı, A. (2021) · Journal of Basic and Clinical Health Sciences · doi:10.30621/jbachs.920675 · Cited by 2 · see citing works

Factors Affecting Drug Resistance and Virulence in Fungal Pathogen

Sharma, P., Kumari, D., Kumari, P., Kumar, A., & Pasrija, R. (2024) · Springer eBooks · doi:10.1007/978-981-97-4909-6_7 · Cited by 1 · see citing works

Susceptibility Test Methods: Yeasts and Filamentous Fungi

Johnson, E. M., & Arendrup, M. C. (2023) · ClinMicroNow · doi:10.1002/9781683674849.mcm0135 · Cited by 1 · see citing works

Susceptibility Test Methods: Yeasts and Filamentous Fungi

Johnson, E. M., & Arendrup, M. C. (2023) · ClinMicroNow · doi:10.1002/9781683670438.mcm0135 · Cited by 1 · see citing works

Echinocandin Resistance

Perlin, D. S. (2017) · Springer eBooks · doi:10.1007/978-3-319-46718-4_29

Estudio proteómico y efecto de la modulación de la vía Calmodulina/Calcineurina en aislamientos de Candida glabrata resistentes a caspofungina

Garzón, C. A. C. (2021) · doi:10.70675/ca271ae5zda04z430ezad9fza9c5574a23ad

Rôle des polysaccharides fongiques et du microbiote intestinal dans la clairance digestive de Candida glabrata

Charlet, R. (2022) · doi:10.70675/11b08f90z8d0dz43efz96ffzf2527c076034

Lineage-specific adaptation and resistance in Candida albicans

Fernandes, M. Z., Maldonado, E., Martinez‐de‐Oliveira, J., Rolo, J., & Palmeira-de-Oliveira, A. (2026) · Fungal Genetics and Biology · doi:10.1016/j.fgb.2026.104116

Echinocandin resistance due to simultaneous FKS mutation and increased cell wall chitin in a Candida albicans bloodstream isolate following brief exposure to caspofungin

Imtiaz, T., Lee, K. K., Munro, C. A., MacCallum, D. M., Shankland, G. S., Johnson, E. M., MACGREGOR, M. S., & Bal, A. M. (2012) · Journal of Medical Microbiology · doi:10.1099/jmm.0.045047-0 · Cited by 32 · see citing works

Fitness and virulence costs of Candida albicans FKS1 hot spot mutations associated with echinocandin resistance.

Ben-Ami, R., Garcia-Effron, G., Lewis, R. E., Gamarra, S., Leventakos, K., Perlin, D. S., & Kontoyiannis, D. P. (2011) · The Journal of Infectious Diseases · doi:10.1093/infdis/jir351 · Cited by 162 · see citing works

Assessing Resistance to the Echinocandin Antifungal Drug Caspofungin in <i>Candida albicans</i> by Profiling Mutations in <i>FKS1</i>

Balashov, S. V., Park, S., & Perlin, D. S. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01653-05 · Cited by 225 · see citing works

Specific Substitutions in the Echinocandin Target Fks1p Account for Reduced Susceptibility of Rare Laboratory and Clinical <i>Candida</i> sp. Isolates

Park, S., Kelly, R., Kahn, J. N., Robles, J., Hsu, M.-J., Register, E., Li, W., Vyas, V., Fan, H., Abruzzo, G., et al. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.8.3264-3273.2005 · Cited by 434 · see citing works

Correlating Echinocandin MIC and Kinetic Inhibition of <i>fks1</i> Mutant Glucan Synthases for <i>Candida albicans</i> : Implications for Interpretive Breakpoints

Garcia-Effron, G., Park, S., & Perlin, D. S. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01162-08 · Cited by 256 · see citing works